Key Findings

Pre-clinical evidence largely shows that CBD can produce beneficial effects in AD, PD and MS patients, but its employment for these disorders needs further confirmation from well designed clinical studies.

Information and Links


Link: Neurological Aspects Of Medical Use Of Cannabidiol

Year: 2017

DOI: 10.2174/1871527316666170413114210


Ratings

(How Ratings Work)

Alzheimer's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Alzheimer's Disease according to the results found in this study.

Parkinson's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Parkinson's Disease according to the results found in this study.

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Epilepsy — 3


Likely probability of the efficacy of cannabis for treatment of Epilepsy according to the results found in this study.

Dravet syndrome — 3


Likely probability of the efficacy of cannabis for treatment of Dravet syndrome according to the results found in this study.

Huntington's Disease — 3


Likely probability of the efficacy of cannabis for treatment of Huntington's Disease according to the results found in this study.

Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) — 3


Likely probability of the efficacy of cannabis for treatment of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) according to the results found in this study.

Drugs Used

CBD